Literature DB >> 9173209

[Value of various intra- and extraoral therapeutic procedures for treatment of obstructive sleep apnea and snoring].

B Schönhofer1, M Wenzel, T Barchfeld, K Siemon, H Rager, D Köhler.   

Abstract

BACKGROUND: Recently intra- and extraoral devices are increasingly used in order to treat obstructive sleep apnea (OSA) and snoring. We examined the value of some devices according to the literature and our own results. PATIENTS AND METHODS: The mandibular advancing devices aim at increasing upper airway diameter. The active part of the tongue extending device (SnorEx) is a stamp connected to a piston which exerts pressure at the base of the tongue causing its forward displacement; we studied 23 patients. The principle of an optically stimulating system ("eye-cover", Snore-Stop) consists of a microphone and light diods which are integrated in the eye-cover. After detecting acoustic signals (for example snoring) optical stimuli are generated in front of the eyes, which are thought to induce arousals causing a change of body position and the reduction of the snoring and apneas; we measured 24 patients. The principle of the tongue-retainer (Snore-Master) is the fixation of the tongue in a ventral position, which is thought to enlarge the mesopharyngeal area; we studied 14 patients. The nose plaster (Breathe-Right) contains an elastic spine that pulls the alae nasi cranial. This manipulation is thought to increase the diameter of the nostril and reduce the airway resistance. We measured 30 patients with obstructive sleep apnea and 20 snoring subjects without obstructive sleep apnea.
RESULTS: Regarding the mandibular advancing due to different appliance designs and study protocols variable success rates have been documented. In patients with mild to moderate obstructive sleep apnea a reduction of the sleep related breathing disorder could be shown. Non compliance (NC) to the tongue extending device was 75% (17/23). Non-compliance-patients were characterized by unacceptable local-side-effects of the prosthesis, lacking improvement of symptoms and of the respiratory disturbance index. Both tongue-retainer and -extensor are characterized by a high incidence of local side effects. Neither the eye-cover nor the nose plaster could improve the severity of obstructive sleep apnoe or snoring. In contrast to another study we could not show a significant effect of the tongue-retainer.
CONCLUSIONS: Neither the nose plaster nor the optical stimulating device influenced the degree of obstructive sleep apnea and snoring. There are conflicting data regarding the tongue retainer. The high rate of non-compliant subjects and the low efficacy of the tongue extending prosthesis precludes large-scale use of this treatment modality in patients with obstructive sleep apnoe and snoring. In selected individuals suffering from a mild to moderate degree of obstructive sleep apnea with CPAP-inefficiency and -incompliance the mandibular advancing principle may be an therapeutic alternative to CPAP.

Entities:  

Mesh:

Year:  1997        PMID: 9173209     DOI: 10.1007/BF03043275

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  31 in total

Review 1.  Management of obstructive sleep apnea.

Authors:  M H Kryger
Journal:  Clin Chest Med       Date:  1992-09       Impact factor: 2.878

2.  [Optical stimulation method (Snore-Stop) and tongue retainer (Snore-Master) without relevance in therapy of obstructive sleep apnea and snoring].

Authors:  M Wenzel; B Schönhofer; G Wenzel; T Barchfeld; D Köhler
Journal:  Pneumologie       Date:  1997-03

3.  [Nasal strips without effect on obstructive sleep apnea and snoring].

Authors:  M Wenzel; B Schönhofer; K Siemon; D Köhler
Journal:  Pneumologie       Date:  1997-12

4.  Effect of anterior mandibular positioning on obstructive sleep apnea.

Authors:  G T Clark; D Arand; E Chung; D Tong
Journal:  Am Rev Respir Dis       Date:  1993-03

Review 5.  Obstructive sleep apnea.

Authors:  P J Strollo; R M Rogers
Journal:  N Engl J Med       Date:  1996-01-11       Impact factor: 91.245

6.  Pathogenesis of upper airway occlusion during sleep.

Authors:  J E Remmers; W J deGroot; E K Sauerland; A M Anch
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-06

7.  A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea.

Authors:  G T Clark; I Blumenfeld; N Yoffe; E Peled; P Lavie
Journal:  Chest       Date:  1996-06       Impact factor: 9.410

8.  Treatment for snoring. Combined weight loss, sleeping on side, and nasal spray.

Authors:  H M Braver; A J Block; M G Perri
Journal:  Chest       Date:  1995-05       Impact factor: 9.410

9.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

10.  A comparative study of treatments for positional sleep apnea.

Authors:  R Cartwright; R Ristanovic; F Diaz; D Caldarelli; G Alder
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

View more
  4 in total

Review 1.  Oral appliances for obstructive sleep apnoea.

Authors:  J Lim; T J Lasserson; J Fleetham; J Wright
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  [Guideline: Treatment of obstructive sleep apnea in adults].

Authors:  T Verse; R Bodlaj; R de la Chaux; A Dreher; C Heiser; M Herzog; W Hohenhorst; K Hörmann; O Kaschke; T Kühnel; N Mahl; J T Maurer; W Pirsig; K Rohde; A Sauter; M Schedler; R Siegert; A Steffen; B A Stuck
Journal:  HNO       Date:  2009-11       Impact factor: 1.284

Review 3.  Impact of impaired nasal breathing on sleep-disordered breathing.

Authors:  Thomas Verse; Wolfgang Pirsig
Journal:  Sleep Breath       Date:  2003-06       Impact factor: 2.816

4.  The use of nasal dilator strips as a placebo for trials evaluating continuous positive airway pressure.

Authors:  Aline C S Amaro; Felipe H G Duarte; Raquel S Jallad; Marcello D Bronstein; Susan Redline; Geraldo Lorenzi-Filho
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.